At the same time, the expiration of key patents is coming up for some major Pfizer drugs, including blood thinner Eliquis and ...
Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.4% during trading on Wednesday . The stock traded as high as $26.65 and ...
PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...
Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...
Range Financial Group LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according ...
Pfizer on Thursday said it will raise its quarterly dividend by 2.4%. The New York-based drug company on Thursday said its board increased its cash dividend to 43 cents a share from 42 cents.
Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.
The stock has lost 12% this year through Monday. Starboard Value's Chief Executive Jeff Smith has publicly accused Pfizer of squandering its Covid successes and has suggested that CEO Albert ...